As drugmakers slam Medicare price controls, Wall Street shrugs
Drugmakers unleashed a broadside at the Inflation Reduction Act, but most will see minimal impacts from price caps – for now.
Related articles
-
Sources: Lions to sign ex-Broncos WR Patrick
August 28, 2024 -
Matsuyama wins opening leg of PGA Tour playoffs
August 18, 2024 -
Hungary PM: no compromise possible with Germany on migration
January 10, 2019
